The estimated Net Worth of Lilian Shackelford Murray is at least $24.4 Thousand dollars as of 18 November 2019. Ms. Murray owns over 5,000 units of Arcadia Biosciences Inc stock worth over $24,379 and over the last 6 years she sold RKDA stock worth over $0. In addition, she makes $0 as Director at Arcadia Biosciences Inc.
Lilian has made over 1 trades of the Arcadia Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 5,000 units of RKDA stock worth $21,250 on 18 November 2019.
The largest trade she's ever made was buying 5,000 units of Arcadia Biosciences Inc stock on 18 November 2019 worth over $21,250. On average, Lilian trades about 556 units every 0 days since 2018. As of 18 November 2019 she still owns at least 8,524 units of Arcadia Biosciences Inc stock.
You can see the complete history of Ms. Murray stock trades at the bottom of the page.
Lilian Shackleford Murray is Director of the Company. Ms. Murray is the founder and manager of Dovedale Investments and managing member of Saints Capital V. She is a former managing director and senior healthcare banker at Prudential Volpe Technology Group and its predecessor, Volpe, Brown Whelan, and held senior positions with Wheat First Securities and Dean Witter Reynolds. Ms. Murray received an MBA from Harvard Business School and a bachelor’s degree from the University of Virginia. Her prior board experience includes service as a director of eMedicine.com, Inc., Extended Care Information Network, Inc. and LifeMasters Supported SelfCare, Inc.
Lilian's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS, TX, 75225.
Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp, and Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.
arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.
Arcadia Biosciences Inc executives and other stock owners filed with the SEC include: